Jianfeng Yang

3PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 11, 2026
Clinical Outcomes, Treatment Patterns, and Molecular Heterogeneity of TFE3-Rearranged Renal Cell Carcinoma: A Multicenter Real-World Study.

|Aug 07, 2026
APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

|May 18, 2021
Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology.

Jinzhou Zheng, Wenhao Xu, Wangrui Liu

Pageof 1

Frequent Collaborators

2 joint publications

Aihetaimujiang Anwaier

2 joint publications

Xi Tian

2 joint publications

Dingwei Ye

2 joint publications

Wenhao Xu